Boekhorst Paul te - Dec 3, 2025 Form 4/A - Amendment Insider Report for IMMUCELL CORP /DE/ (ICCC)

Role: President and CEO, Director
Signature: /s/ Timothy C. Fiori Attorney-in-Fact
Stock symbol: ICCC
Transactions as of: Dec 3, 2025
Transactions value $: $31,528
Form type: 4/A - Amendment
Date filed: 12/4/2025, 04:11 PM
Date Of Original Report: Dec 3, 2025
Previous filing: Dec 3, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
te Boekhorst Paul Francis Olivier	President and CEO, Director	C/O IMMUCELL CORPORATION, 56 EVERGREEN DRIVE, PORTLAND	/s/ Timothy C. Fiori Attorney-in-Fact	2025-12-04	0002095704

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ICCC	Common Stock $0.10 par value per share	Purchase	$18.2K	+3.6K	+97.03%	$5.05	7.31K	Dec 3, 2025	Direct	F1
transaction	ICCC	Common Stock $0.10 par value per share	Purchase	$13.4K	+2.43K	+33.29%	$5.50	9.74K	Dec 4, 2025	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased.
F2	This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased, and the correct transaction date.